CD274 and non-small cell lung carcinoma: It has been hypothesized that PD-L1 expression on CTCs may mediate immune escape [19] and a study in NSCLC patients receiving anti-PD-L1 therapy revealed a trend toward a reduction in PD-L1-positive CTCs in patients obtaining clinical benefit [20].